|
Volumn 17, Issue 17, 2007, Pages 4895-4900
|
Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors
|
Author keywords
HDAC; HDAC inhibitor; Hydroxamic acid; Isoindoklinone; p21; Pancreatic cancer
|
Indexed keywords
HISTONE DEACETYLASE INHIBITOR;
HYDROXAMIC ACID DERIVATIVE;
VORINOSTAT;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL;
CELL PROLIFERATION;
DRUG DESIGN;
DRUG INHIBITION;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
PANCREAS CANCER;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
ENZYME INHIBITORS;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HISTONE DEACETYLASES;
HUMANS;
HYDROXAMIC ACIDS;
INDOLES;
PANCREATIC NEOPLASMS;
UP-REGULATION;
|
EID: 34547592204
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2007.06.038 Document Type: Article |
Times cited : (57)
|
References (24)
|